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The unconventional myosin CRINKLED and
its mammalian orthologue MYO7A regulate
caspases in their signalling roles
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Caspases provide vital links in non-apoptotic regulatory networks controlling inﬂammation,
compensatory proliferation, morphology and cell migration. How caspases are activated
under non-apoptotic conditions and process a selective set of substrates without killing the
cell remain enigmatic. Here we ﬁnd that the Drosophila unconventional myosin CRINKLED
(CK) selectively interacts with the initiator caspase DRONC and regulates some of its
non-apoptotic functions. Loss of CK in the arista, border cells or proneural clusters of the
wing imaginal discs affects DRONC-dependent patterning. Our data indicate that CK acts
as substrate adaptor, recruiting SHAGGY46/GSK3-b to DRONC, thereby facilitating
caspase-mediated cleavage and localized modulation of kinase activity. Similarly, the
mammalian CK counterpart, MYO7A, binds to and impinges on CASPASE-8, revealing a
new regulatory axis affecting receptor interacting protein kinase-1 (RIPK1)4CASPASE-8
signalling. Together, our results expose a conserved role for unconventional myosins in
transducing caspase-dependent regulation of kinases, allowing them to take part in speciﬁc
signalling events.
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D
eregulation of caspases forms the basis of many human
disease pathogeneses including neurodegeneration and
cancer1. Although caspases have been extensively studied
as initiators, executioners or regulators of cell death mediated
by apoptosis, pyroptosis, necroptosis or autophagy2, it is clear
that caspases actively regulate animal development and the
defense of homeostasis through both cell death-dependent and
-independent functions3–5. Caspase activation requires the
recruitment of initiator caspases into macromolecular protein
complexes that mediate the activation of initiator caspases
through proximity-induced dimerization. Activation of initiator
caspases depends on the engagement of platforms such as the
death-inducing signalling complex, complex-II or ripoptosome
for CASPASE-8 (CASP8) or CASP10, the apoptosome for CASP9
and the inﬂammasome for CASP-1 or -11 (ref. 6). These
platforms integrate cellular signals and recruit initiator caspases
via their death-fold domain, which results in the dimerization
of the initiator caspases and formation of an active enzyme6.
An important outstanding question is how caspases can be
activated to mediate non-apoptotic events without killing the cell.
Hypotheses that have been suggested include temporal restriction
of activity and amplitude modulation (see ref. 3); however, it is
not clear how general these modes of regulation are.
By studying how caspases take part in non-apoptotic signalling,
we unexpectedly discovered an evolutionary conserved principle
of caspase-mediated control of cellular processes. We ﬁnd
that in both Drosophila and mammals, an unconventional
myosin is essential for caspase-mediated regulation of kinases.
Our data demonstrate that the Drosophila myosin family member
CRINKLED (CK) and its mammalian counterpart Myosin VIIA
(MYO7A) act as substrate adaptor for kinases, thereby facilitating
caspase-mediated cleavage and localized modulation of kinase
activity. In mammals, this results in inactivation of RIPK1 and
suppression of CASP8. In the absence of MYO7A, CASP8-
mediated cleavage and inactivation of RIPK1 is less effective. This
has important implications, because mutations in MYO7A cause
Usher syndrome 1B—an autosomal recessive disorder character-
ized by bilateral sensorineural hearing loss and blindness due to
retinitis pigmentosa. Despite intense investigation, the mechan-
isms by which loss of MYO7A results in deafness and blindness
are poorly understood. Our ﬁnding that MYO7A interacts with
the initiator CASP8 and dampens its activation may help to
explain why patients with mutations in MYO7A suffer progres-
sive loss of sensory neurons. Given that RIPK1 and CASP8 take
part in the defense of homeostasis downstream of many cytokine
receptors, it is plausible that inﬂammatory signals contribute to
the onset and progression of retinitis pigmentosa in patients with
MYO7A mutations due to aberrant activation of RIPK1-dependent
cell death.
Results
CK modulates DRONC-dependent phenotypes. To elucidate
how caspases are regulated in their apoptotic and non-apoptotic
roles, we set out to identify new binding partners of the Droso-
phila initiator caspase DRONC. To this end, an HA3x-tagged
form of DRONC was stably expressed in Drosophila Schneider
cells (S2). DRONC protein complexes were isolated via large-scale
afﬁnity puriﬁcation from Drosophila S2 cells using a-HA resin
followed by mass spectrometric analysis. As controls, we used
cells stably expressing HA3x-tagged forms of green ﬂuorescent
protein (GFP), DARK, DIAP1, DIAP2, DREDD, dTAK1, dTAB2,
RELISH, KENNY and IRD5. Using DRONC as an afﬁnity
reagent, we identiﬁed a total of 89 proteins with a minimum
score of two unique peptides (Supplementary Table 1). CK, the
Drosophila orthologue of mammalian non-muscle MYO7A
selectively co-puriﬁed with DRONC (Fig. 1a–c). Although we
identiﬁed ﬁve unique CK-derived peptides in DRONC immuno-
precipitates, no such peptides were identiﬁed in control immu-
noprecipitates, highlighting the selectivity of the CK–DRONC
interaction (Supplementary Table 1). Reciprocal co-immunopre-
cipitation assays demonstrated that CK speciﬁcally associated with
DRONC, while it did not interact with GFP, DIAP1 or drICE
(Fig. 1b,c). To identify the regions of DRONC and CK that are
required for their interaction, we tested several DRONC and CK
fragments for their ability to bind to CK or DRONC, respectively.
We found that CK preferentially bound to the CARD-containing
pro-domain of DRONC (Fig. 1d). In addition, CK also weakly
interacted with the p20-p10 region of DRONC, suggesting that the
interaction between CK and DRONC is mediated by multiple
contact points. The CARD domain of DRONC interacted with the
amino-terminal portion of CK (CK1–997) encompassing the myo-
sin head and IQ motifs (Fig. 1e), whereas the caspase domain of
DRONC (p20-p10) region associated with the central region of CK
(CK998–1,668) (Fig. 1f).
CK represents an unconventional, non-muscle myosin that is
highly conserved from ﬂies to man, sharing 73% amino acid
sequence similarity to its human counterpart MYO7A (Fig. 1a).
MYO7A is expressed in numerous epithelial cell types, suggesting
a role in multiple cellular processes. Mutations of MYO7A
in humans cause Usher syndrome 1B (Fig. 1a), an autosomal
recessive disorder characterized by bilateral sensorineural hearing
loss and blindness due to retinitis pigmentosa7. Despite intense
investigation, the mechanisms by which loss of MYO7A results in
deafness and blindness are poorly understood8. In Drosophila,
a loss-of-function mutation in CK (ck13) causes early embryonic
lethality9, indicating that CK is indispensable for normal
development. To investigate the functional signiﬁcance of the
interaction between CK and DRONC, we examined the
requirement of CK in head involution defective (HID)-
mediated eye ablation (Fig. 2a). Expression of the inhibitor of
apoptosis (IAP) antagonist HID in the eye activates DRONC-
dependent cell death, resulting in a small eye phenotype that is
sensitive to the dosage of regulatory genes that control
components of the apoptotic machinery10–17. Using the
previously described GheF (GMR-hid ey-FLP) method18, we
found that eye-speciﬁc loss of CK (ck13 homozygous mutant
clones in the eye) signiﬁcantly protected from the GMR-hid
induced eye-ablation phenotype (Fig. 2a). Importantly, loss of ck
function did not affect expression of HID protein, ruling out the
possibility that ck13 suppresses the HID eye phenotype by altering
HID protein levels (Supplementary Fig. 1a–d). Similar to genetic
deletion of ck, RNA interference (RNAi)-mediated knockdown of
ck also suppressed HID- and REAPER (RPR) killing in the eye
(Supplementary Fig. 1e–h). Together, our data indicate that CK
binds to DRONC and can contribute to DRONC-dependent
phenotypes, such as efﬁcient induction of cell death in response
to high-level expression of the IAP antagonists HID and RPR.
To study the physiological role of CK in regulating DRONC,
we investigated various paradigms of DRONC-mediated apopto-
tic and non-apoptotic signalling events. Rare adult ‘escapers’
of ck13 mutant ﬂies that occasionally emerge exhibit aristae,
which are more highly branched than normal9 (Fig. 2b and
Supplementary Fig. 1i). Interestingly, branching of the Drosophila
arista is regulated by DRONC19,20, an initiator caspase that is
controlled by DIAP1 (ref. 11). Accordingly, surviving ﬂies
carrying the semi-lethal nonsense mutations DroncI24 or
DroncI29 display extra aristal branches compared with wild-type
controls19. Likewise, suppression of DRONC activity via RNAi-
mediated inactivation of Drosophila Ikk, DmIKKe (also known as
Ik2), which results in an increase in DIAP1 levels and lower
DRONC activity20, causes excessive branching of the arista
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Figure 1 | CK selectively interacts with DRONC. (a) Schematic representation of MYO7A from human (Homo sapiens), zebraﬁsh (Danio rerio) and
Drosophila (D. melanogaster). Top: more than 120 mutations in the MYO7A gene have been identiﬁed in patients with Usher syndrome type 1B
(http://mutdb.org/products/search). Indicated are 34 selected mutations in human MYO7A and the respective mariner mutations of zebraﬁsh MYO7A.
The loss-of-function mutation in CK (ck13) is indicated. (b) MYC-GFP or MYC-DRONC was co-expressed with HA-CK in Drosophila S2 cells.
a-MYC-immunoprecipitation was performed and CK interaction was assessed via immunoblotting. (c) V5-DRONC, V5-drICE or V5-DIAP1 was
co-expressed with HA-CK or HA-GFP in S2 cells. a-HA immunoprecipitation was performed and binding to CK or GFP was determined by immunoblotting.
(d) V5-tagged full-length DRONC, DN DRONC (see scheme in a) or DRONC CARD (CARD) were co-expressed with HA-CK. a-HA immunoprecipitation was
performed and binding to CKwas determined by immunoblotting. (e) V5-CARD of DRONCwas co-expressed with the indicated HA-tagged fragments of CK.
a-HA immunoprecipitation was performed and binding to CK was determined by immunoblotting. (f) V5-tagged full-length DRONC was co-expressed
with the indicated HA-tagged fragments of CK. a-HA immunoprecipitation was performed and binding to CK was determined by immunoblotting.
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(Fig. 2b) (refs 9,21). Ectopic branching is also observed in hid
mutants22. Although failure to activate DRONC results in ectopic
branching, a branchless or thread-like phenotype of the arista is
observed in ﬂies that carry the DIAP1 loss-of-function mutant
thread1 22. This indicates that controlled activation of DRONC is
required for proper arista morphogenesis. The notion that CK
interacts with DRONC, and ck13 and Dronc mutants display extra
branches of the arista strongly suggests that CK regulates
DRONC in the arista.
Next, we investigated the role of CK in regulating devel-
opmentally controlled or stress-induced apoptosis. A large
amount of naturally occurring cell death is observed anterior to
the morphogenetic furrow in the third-instar larval eye disc23 and
this cell death was not suppressed in ck13 mutant clones
(Supplementary Fig. 2a,b). We also examined pupal eye
development, during which apoptosis is required to remove
excess interommatidial cells. We found that the number of
interommatidial cells was not affected in ck13-null clones
(Supplementary Fig. 2c,d) (two-tailed t-test: P¼ 0.38). Loss of
ck also did not affect X-irradiation-induced DRONC activation in
the wing discs of third-instar larvae (Supplementary Fig. 2e).
Together, these data indicate that CK does not regulate DRONC
in its apoptotic role in the ﬂy. It is possible that although strong
expression of HID and RPR promote cell death through CK-
assisted activation of DRONC, CK-mediated DRONC activation
might not be a rate-limiting factor during naturally occurring cell
death scenarios where apoptosis is executed through the
concerted action of mitochondrial-dependent and -independent
mechanisms13,24–26.
CK is required to suppress extra macrochaete in the scutellum.
Caspase activity without cell death controls various physiological
processes, including cell differentiation and cell migration3–5;
however, the regulatory mechanisms of caspase activity in this
context are largely unknown. With this in mind, we examined the
effects of CK loss on caspase-mediated signalling events,
independent of cell death. The development of sensory organ
precursor (SOP) cells and the correct number of macrochaete
(large bristles) on the scutellum of the notum are determined
through a non-apoptotic signalling function of DRONC21,27
(Fig. 3a). Non-apoptotic DRONC activation is achieved through
DmIKKe-mediated depletion of DIAP1 protein levels in cells of
the proneural cluster that gives rise to SOPs. Partial depletion of
DIAP1 causes caspase activation and caspase-mediated cleavage
of the inactive GSK3b precursor SHAGGY (SGG) 46 protein.
This cleavage converts it to the active kinase SGG10, which
contributes to SOP cell speciﬁcation21,27 (Fig. 3a), allowing the
formation of precisely four macrochaete on the scutellum.
However, ectopic macrochaete develop if caspase activation or
activity is suppressed21,27. Thus, we examined whether loss of ck
phenocopies depletion of Dronc, sgg and DmIKKe in specifying
numbers of macrochaete in the scutellum. Knockdown of ck in
the scutellum, using the scabrous-GAL4 (Sca-GAL4) driver,
resulted in the appearance of extra macrochaete in 32% of ﬂies
(n¼ 110; Fig. 3b,d,e). This was reminiscent of the effects of Dronc
RNAi (26%, n¼ 142), sgg RNAi (26%, n¼ 137) and DmIKKe
RNAi (59%, n¼ 104) (Fig. 3b,c,e). Interestingly, depletion of ck
phenocopies expression of a non-cleavable form of SGG46
(sgg46D235G/D300G 27, thereafter referred to as sgg46D4G), which
causes the appearance of ectopic macrochaete in B19.3% of
animals27. This suggests that SGG46 fails to be cleaved in the
absence of ck. Although knockdown of ck resulted in extra
macrochaete, RNAi against the closely related gene myo28B
(the orthologue of mammalian Myo7B) did not lead to the
formation of extra machrochaete (n¼ 146) (Fig. 3e). This
suggests that CK, but not MYO28B, is required for DRONC
activation in proneural clusters.
Consistent with the phenotype obtained by ck RNAi, expres-
sion of a dominant-negative (DN) form of CK (CKTAIL (ref. 28))
also resulted in ectopic macrochaete in B42% of ﬂies (n¼ 78),
compared with 8% in controls (n¼ 165). Expression of CKTAIL
enhanced the ectopic macroachaete phenotype caused by
DmIKKe RNAi (Fig. 3e). These observations suggest that CK
regulates DRONC in its non-apoptotic role in proneural clusters,
to determine the correct number of SOP cells.
To gain insight into the mechanism by which CK regulates the
number of macrochaete, we investigated whether CK might
function as a substrate adaptor linking DRONC to SGG46 and
facilitating its conversion to SGG10. Binding assays revealed that
CK speciﬁcally co-puriﬁed SGG46 from cellular extracts, whereas
it did not associate with DmIKKe under the same conditions
(Fig. 4a). Intriguingly, CK bound exclusively to the inactive
GSK3b precursor SGG46 and did not associate with SGG10
(Fig. 4b). Given that CK interacts with both DRONC and the
precursor form of SGG46, and that loss of ck phenocopies loss of
b
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Dark, Dronc and sgg or expression of SGG46D4G, our data
suggest a mechanism whereby CK acts as a substrate adaptor
bringing SGG46 in close proximity to the caspase, thereby
facilitating cleavage and localized activation of SGG46. According
to this scenario, following caspase-mediated cleavage, active
SGG10 is then released to regulate SOP cell speciﬁcation. To gain
a better understanding why CKTAIL acts as a DN mutant, we
tested the ability of CKTAIL to bind to DRONC. As shown in
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Supplementary Fig. 3a, CKTAIL bound to DRONC as efﬁciently as
wild-type CK. As CK helps to recruit substrates (such as SGG46) to
DRONC, it is likely to be that CKTAIL fails to associate with
caspase substrates. Thus, CKTAIL may function as DN, because it
prevents the recruitment of caspase substrates to DRONC.
Validation of how CK modulates DRONC signalling will
ultimately require the reconstitution of stable DARK/DRONC/
drICE/CK/SGG46 protein complexes. Attempts to reconstitute this
complex in vitro have been hampered by difﬁculties in producing
recombinant CK due to its sheer size (2,176 amino acids).
DN forms of CK rescue the RacN17 migration defect. The
migration of border cells in the developing egg chamber is
another non-apoptotic developmental process in which DmIKKe
and DRONC have been implicated29. Border cell migration
provides a simple model to study how cells that originate within
an epithelial monolayer subsequently become migratory. Border
cells undergo ‘collective cell migration’ from the anterior pole of
the developing egg chamber towards the oocyte, reaching their
destination by stage 10 of oocyte development. The collective
migration of border cells is dependent on the activity of the small
GTPase RAC. Expression of a DN form of RAC (RACN17) almost
entirely blocked migration of the border cell cluster29
(Fig. 5a,b,d,f,h,i). Importantly, this migration defect can be
rescued through suppression of DRONC activity, either by
mutations affecting DARK, expression of a DN form of DRONC
(DRONCDN) or expression of DIAP1 (ref. 29). The role for
DRONC in negatively regulating RAC-mediated cell motility
represents an apoptosis-independent function of DRONC. Given
that the migratory phenotype of RACN17-expressing border cells
is sensitive to DRONC activity, we assessed whether CK is
required for DRONC activation in border cells. Normal border
cells complete migration to 100% at stage 10 (Fig. 5c,h,i). In
contrast, slbo-GAL4-driven expression of UAS-RacN17 resulted in
severe migration defects in which none of the border cell clusters
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reached their ﬁnal destination (Fig. 5d,h,i). Less than 2% of
RACN17-expressing egg chambers had border cell clusters that
reached halfway to their presumptive destination. Importantly,
expression of CKTAIL suppressed the RACN17 migration defect
signiﬁcantly, with 43.5% of egg chambers having border cells that
migrated at least halfway to the oocyte (Fig. 5e,h). The ability of
CKTAIL to rescue the RACN17 was comparable to that of
DRONCDN, expression of which resulted in 51.2% of egg
chambers having border cells that migrated at least halfway
to the oocyte (Fig. 5h). Although no RACN17 egg chambers had
border cells that migrated beyond 75% of the total distance,
expression of DN forms of CK and DRONC rescued the
RacN17 phenotype, allowing border cells in 19.6% and 26.8%,
respectively, of the egg chambers to migrate further than 75% of
their distance. Given that CKTAIL phenocopies DRONCDN in
rescuing the RACN17 migration phenotype, our data further
demonstrate a functional interaction between CK and DRONC,
and are consistent with the notion that CK contributes to
DRONC-mediated non-apoptotic signalling.
Next, we addressed whether CK affects caspase signalling
through a common mechanism in these multiple models of
caspase function. During SOP speciﬁcation, CK seems to function
as substrate adaptor that helps to bridge DRONC and SGG46. To
test the role of SGG46 cleavage in border cell migration, we
expressed SGG46D4G that cannot be cleaved27 (Fig. 5f,g,i). If the
RACN17 migration defect was mediated by DRONC-dependent
cleavage of SGG46, the prediction is that a non-cleavable form
of SGG46 would phenocopy DRONCDN and CKTAIL, and
rescue the RACN17 block in migration. Indeed, expression of
SGG46D4G rescued the RACN17 migration phenotype
(Fig. 5f,g,i). Importantly, the ability of SGG46D4G to rescue the
RACN17 phenotype was comparable to the effect of DRONCDN
and CKTAIL (Fig. 5 and also compare Fig. 5h with Fig. 5i). This
also demonstrates that cleavage of a single substrate is sufﬁcient
to mediate the RACN17 phenotype. Given that SGG46D4G
phenocopies CKTAIL and DRONCDN in rescuing the RACN17
migration phenotype, our data are consistent with the notion that
RACN17 drives CK-mediated activation of DRONC, which results
in caspase-dependent cleavage and activation of SGG46. Activation
of SGG subsequently suppresses border cell migration, most
probably by inﬂuencing the dynamics of actin cytoskeleton,
microtubule and adhesion turnover.
We further investigated the role of CK in regulating two
other caspase-dependent signalling pathways, Drosophila innate
immune signalling and spermatid individualization. We found
that CK speciﬁcally interacted with the death-domain-containing
protein immune deﬁency (IMD) and ameliorated IMD signalling
following septic injury with the Gram-negative bacteria Ecc15
(Supplementary Fig. 3b–d). This is consistent with an earlier
report implicating CK as a putative negative regulator of IMD
signalling30. Although CK regulates initiator caspases in their
non-apoptotic roles in border cells, SOP and arista, CK appeared
to play no rate-limiting role in DRONC-mediated
individualization of spermatids (Supplementary Fig. 3e).
Together, our data demonstrate that CK regulates caspases in
some but not all signalling aspects. Quite possibly, SGG46 is only
involved in border cells, SOP, arista and fat body cells (for IMD
signalling), but not in spermatids.
MYO7A binds to CASP8 in a RIPK1-dependent manner.
Human MYO7A shares 73% amino acid sequence similarity to
Drosophila CK. Mutations inMYO7A cause Usher syndrome type
1B, a disease characterized by the combination of sensorineural
hearing loss and visual impairment termed retinitis pigmentosa7.
Previous studies of the mutant zebra ﬁsh mariner, which carries a
mutation in myo7aa (the zebra ﬁsh homologue of MYO7A),
revealed mild endoplasmic reticulum (ER) stress and sensory
neuron apoptosis31. However, the mechanism through which
such MYO7A alleles render cells susceptible to apoptosis remains
ill deﬁned. Given that CK directly interacts with the initiator
caspase DRONC, we assessed whether MYO7A might bind and
regulate caspases. To this end, we tested the ability of mammalian
MYO7A to associate with CASP8, CASP9 and the effector
CASP3. Intriguingly, we found that MYO7A selectively bound to
CASP8, whereas it failed to associate with CASP3 or CASP9
under the same experimental conditions (Fig. 6a). The binding of
CASP8 to MYO7A was mediated by the death effector domain
(DED) of CASP8, as this domain in isolation speciﬁcally
interacted with MYO7A (Fig. 6b). Consistently, deletion of the
DED (DN-CASP8) completely abrogated the binding of CASP8
to MYO7A, indicating that MYO7A only binds to pro-CASP8.
To investigate the localization and interaction of endogenous
MYO7A and CASP8, we performed immunoﬂuorescence con-
focal microscopy. Staining with MYO7A- and CASP8-speciﬁc
antibodies revealed that the expression of endogenous MYO7A
closely overlapped with that of CASP8 (Fig. 6c and
Supplementary Fig. 4a). Two different a-CASP8 antibodies, when
combined with a-MYO7A antibodies, provided identical results
(compare Fig. 6c with Supplementary Fig. 4a).
To visualize MYO7A/CASP8 protein interaction in their native
state in intact cells, we applied in situ proximity ligation assay
(PLA)32 with a combination of antibodies that generate a
localized, discrete signal only when CASP8 and MYO7A are in
close proximity, that is, in a complex. Using speciﬁc primary
antibodies against CASP8 and MYO7A, which in turn were
recognized by oligonucleotide-coupled secondary antibodies, we
obtained discrete proximity labelling of CASP8 and MYO7A,
conﬁrming their close proximity (Fig. 6d). Virtually, the same
result was obtained using two different primary a-CASP8
antibodies (Fig. 6d and Supplementary Fig. 4b). To control for
nonspeciﬁc binding between the various secondary antibodies, we
added only one or no primary antibody to the reaction and
observed no signal (Fig. 6d). Intriguingly, MYO7A/CASP8
proximity labelling was entirely dependent on the presence of
RIPK1. Accordingly, depletion of Ripk1 by RNAi completely
abolished CASP8/MYO7A proximity signals (Fig. 6d, compare
d(ii) and d(iii) with d(iv)). This result also demonstrates that the
observed proximity signal is not due to nonspeciﬁc binding of the
primary antibodies. The requirement of RIPK1 for the generation
of CASP8/MYO7A proximity signals strongly suggests that
CASP8 and MYO7A interact with one another within RIPK1-
based protein complexes such as the ripoptosome.
MYO7A suppresses ripoptosome formation. RIPK1 can form
protein complexes in the cytosol with CASP8, cFLIP (cellular
FLICE-like inhibitory protein) and Fas-associated protein with a
death domain (FADD). Depending on the signals that stimulate the
assembly of RIPK1-based protein complexes, this complex is
referred to as complex-II or ripoptosome33–37. Active CASP8 within
complex-II/ripoptosome cleaves and inactivates RIPK1, thereby
counteracting the assembly and stability of this complex38,39.
The complex-II/ripoptosome is further negatively regulated by the
E3 ubiquitin-ligases cIAP1, cIAP2 and XIAP, which target
this complex for Ub-dependent inactivation33. When IAPs
and/or CASP8 are inhibited, complex-II/ripoptosome complexes
signiﬁcantly accumulate and are stabilized40. Consistent with the
notion that PLA can be adapted to detect complex-II/ripoptosome
in situ, we found that speciﬁc primary antibodies against RIPK1 and
CASP8 resulted in RIPK1/CASP8 proximity signals (Fig. 7a–i).
Importantly, these proximity signals were signiﬁcantly enhanced
when IAPs and/or CASP8 were inhibited, such as following
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treatment with pharmacological inhibitors of IAPs (second
mitochondria-derived activator of caspase mimetic, SM)
(Fig. 7a(ii)) and stable expression of the viral CASP8 inhibitor
CrmA (Fig. 7a(iii)). This is entirely consistent with co-immuno-
precipitation experiments, demonstrating that the ripoptosome is
stabilized following treatment with SM or CASP8 inhibitors33,34.
The notion that the proximity technique reliably detects complex-
II/ripoptosome formation in situ is further corroborated by the
observation that treatment with tumour necrosis factor (TNF)/
SM, which drives RIPK1-dependent formation of complex-II (ref.
35), resulted in a dramatic increase in RIPK1/CASP8 proximity
signals within a few hours (Fig. 7b).
TNF is a pleiotropic cytokine inducing a variety of cellular
responses ranging from inﬂammatory cytokine production, cell
survival, cell proliferation and, paradoxically, CASP8-dependent
cell death41,42. Although it is clear that many human
pathogeneses are caused by deregulated TNF signalling, recent
evidence suggests that some TNF-driven diseases might not only
be due to aberrant TNF-mediated activation of nuclear factor-kB
and the production of cytokines43, but also might be the result of
deregulated TNF-induced cell death44. In this respect, it is
interesting to note that TNF contributes to the neurotoxicity
observed in retinal neurodegenerative disorders45. Given that
mutations in MYO7A sensitize cells to apoptosis and retinitis
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pigmentosa31,46, and that MYO7A can interact with CASP8 in a
RIPK1-dependent manner (Fig. 6d(iv)), we assessed whether
MYO7A modulates TNF-dependent formation of complex-II/
ripoptosome. Intriguingly, we found that RNAi-mediated
knockdown of MYO7A enhanced TNF-induced formation of
RIPK1/CASP8 complexes (Fig. 7c and compare Fig. 7c(iii) with
Fig. 7c(iv)).
Loss of MYO7A sensitizes cells to cytokine-induced cell death
in a CASP8-dependent manner. Consistent with the notion that
depletion of MYO7A caused enhanced formation of RIPK1/
CASP8 complexes, we found that this was accompanied with
enhanced processing and activation of CASP8, elevated levels of
effector caspase activity (DEVDase) and reduced cell viability
(Fig. 8a–c and Supplementary Fig. 4). Under the same conditions,
knockdown of Casp8 or Ripk1 suppressed caspase activation
(Fig. 8 and Supplementary Fig. 4), demonstrating that the
enhanced cytotoxic effect of TNF on depletion of MYO7A is
RIPK1 and CASP8 dependent. In all cell lines tested, knockdown
of MYO7A enhanced TNF-induced caspase activation and cell
death (Supplementary Fig. 4), extending this observation to other
cell types. Therefore, these data indicate that MYO7A contributes
to the proper regulation of CASP8, protecting cells from the
cytotoxic effects of cytokines such as TNF. The observation that
MYO7A binds to the DED of CASP8 (Fig. 6b) is particularly
intriguing, because for full activation CASP8 requires sequential
interaction of CASP8 molecules, via their DED domains, to form
a caspase-activating chain47. As MYO7A binds to the DED of
CASP8 and dampens its activation, it is possible that MYO7A
suppresses the formation of CASP8 chains, thereby acting as a
chain terminator. Alternatively, MYO7A might regulate the
stability/turnover of complex-II/ripoptosome. A characteristic
feature of complex-II/ripoptosome is that it regulates its own
stability38,39. Once RIPK1 adopts a binding-competent state, it
recruits FADD, CASP8 and cFLIPL. FLIPL-mediated activation of
CASP8 results in cleavage of RIPK1, which results in disassembly
of the complex. Given that depletion of MYO7A results in
enhanced complex formation (Fig. 7c(iv)), it is possible that the
presence of MYO7A favours CASP8-mediated cleavage of RIPK1
and disassembly of the complex. This would be reminiscent to the
situation in Drosophila where CK helps DRONC to drive the
cleavage of SGG46. In the absence of MYO7A, less RIPK1 would
be cleaved, which results in a build-up of complex-II/ripoptosome
formation (as evidenced in Fig. 7c(iv)), which in turn would lead
to enhanced caspase activation. According to this scenario,
MYO7A would not actually change the activity of CASP8 but
alter the stability of complex-II/ripoptosome. These two models
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are not mutually exclusive, as both mechanisms could operate
simultaneously. Ultimately, quantitative and structural mass
spectrometric approaches will be necessary to determine the
stoichiometry of RIPK1, FADD, CASP8 and FLIPL in the
presence and absence of MYO7A.
Discussion
Usher syndrome, the leading cause of hereditary combined
hearing and vision loss, is characterized by sensorineural deafness
and progressive retinal degeneration7. Mutations in several
different genes produce Usher syndrome; however, the
proximal cause of sensory cell death remains unknown. Our
ﬁnding that MYO7A interacts with the initiator CASP8 and
dampens its activation may help to explain why patients with
mutations in MYO7A suffer progressive loss of sensory neurons.
Given that RIPK1 and CASP8 take part in the defense of
homeostasis downstream of many cytokine receptors, it is
possible that inﬂammatory signals such as TNF contribute to
the onset and progression of retinitis pigmentosa due to aberrant
activation of RIPK1-dependent cell death. Our ﬁndings have
important implications, as they suggest that anti-inﬂammatory
biologics, such as Enbrel (a TNF blocker), might help to delay or
even prevent the onset of this debilitating disease. Although
CASP8 can initiate apoptosis downstream of TNF death
receptors, the normal physiological function of CASP8 is to
transmit a pro-survival signal that suppresses RIPK1-dependent
necroptosis. Suppression of RIPK1-dependent necroptosis by
CASP8 requires its catalytic activity. One of the key substrates
processed by CASP8 is RIPK1. This destabilizes RIPK1-based
death complexes38,39. The observation that RIPK1-based
platforms accumulate on depletion of MYO7A might indicate
that CASP8-mediated cleavage and inactivation of RIPK1 is less
effective in the absence of MYO7A. This is highly reminiscent of
the situation in Drosophila, where CK assists DRONC in cleaving
the kinase SGG46. Thus, in both Drosophila and mammals, CK
and MYO7A appear to take part in caspase-mediated regulation
of kinases, revealing a unifying principle of caspase-mediated
regulation of cellular processes (Fig. 9).
Methods
Reagents. Constructs were generated by PCR and cloned into pAc, pMT,
pcDNA3 (Invitrogen) or pEF6 and veriﬁed by sequencing. Speciﬁc point mutations
were generated using site-directed mutagenesis with Pfu Turbo polymerase (Stra-
tagene). The Ub-sgg10 fusion construct was generated by PCR using Easy-A
polymerase and cloned into pMT-V5/His. The following antibodies were used:
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a-MYC (Sigma, M5546, 1:2,000), a-HA (Roche, 11867423001, 1:2,000), a-V5
(Serotec, MCA1360, 1:2,000), a-RIPK1 (BD Biosciences, 610459,1:1,000 for
western blotting (WB) and 1:50 for immunoﬂuorescence studies), a-Actin (Santa
Cruz, sc-1615, 1:4,000), a-MYO7A (Developmental Studies Hybridoma Bank,
138-1-s, 1:1,000 for WB and 1:50 for immunoﬂuorescence studies), a-CASP8 for
WB (MBL, M032-3, 1:5,000), a-CASP8 to detect cleaved CASP8 (for human: R&D,
AF1650, 1:2,000; for mouse: Cell Signaling Technology, 9429, 1:1,000), rabbit and
goat a-CASP8 (Santa Cruz Biotechnology, sc-7890 and sc-6136, both 1:50 for
immunoﬂuorescence studies), CF488A-donkey a-mouse IgG (Biotium, A21202,
1:1,000), CF633-donkey a-rabbit IgG (Biotium, 20125, 1:1,000) and CF633-donkey
a-goat IgG (Biotium, 20127, 1:1,000). SM (SM164) was a gift from Shaomeng
Wang (University of Michigan) and TNF was obtained from Enzo Life Sciences.
Uncropped WBs are shown in Supplementary Fig. 5.
Fly stocks. Flies were raised at 25 C according to standard procedures, unless
stated otherwise. RNAi stocks were obtained from the Vienna Drosophila
RNAi Center, with the exception of GFP RNAi (a gift from R. Ueda) and LacZ
RNAi (a gift from M. Miura). UAS-GFP-ckTAIL was a gift from D. Kiehart.
UAS-DmIKKeG250D (DN-DmIKKe) and UAS-sgg46D235G/D300G were gifts from
M. Miura. GMR-hid,ey-FLP were previously described18. All other stocks were
obtained from the Bloomington Drosophila Stock Center or described previously.
Quantiﬁcation of macrochaete. Crosses were performed at 18 C. The macro-
chaete on the scutellum and the central portion of the notum were analysed. Any
macrochaete that were present in addition to the usual numbers (four on the
scutellum and four on the central part of the notum) were scored as ectopic
macrochaete.
Border cell migration. Ovaries were dissected in PBS, ﬁxed in 4% formaldehyde
for 20min and permeabilized in PBS containing 0.1% Tween 20. Ovaries were
stained with 4,6-diamidino-2-phenylindole and phalloidin (Invitrogen). After
mounting in Vectashield Hardset Mounting Medium (Vector Laboratories), con-
focal images of stage-10 egg chambers were taken. The distance the border cells had
moved was measured using ImageJ software in at least 30 stage-10 egg chambers
and expressed as a percentage of the total distance from the anterior pole to the
oocyte.
Tissue culture and confocal microscopy. Drosophila S2 cells and mammalian
SKOV3, HT1080, NIH3T3 and Swiss3T3 were obtained from ATCC. SKOV3CrmA
were described in ref. 33. Small interfering RNA (siRNA) oligos are as follows:
human Ripk1 siRNA: 50-CCAACUAUCUAGGAAAUACtt-30 ; human Myo7A: 50-
GGACGGGUGUGUACUUUGU-30 ; non-targeting: AllStars Negative control-
1027281 (Qiagen) (for mouse and human); mouse Myo7A-1: (Qiagen)
Mm_Myo7a_1 FlexiTube siRNA, Cat:SI01322279; mouse Myo7A: (Qiagen)
Mm_Myo7a_2 FlexiTube siRNA, Cat:SI01322286; mouse Ripk1: 4390771-
ID:s72977 (Ambion); and mouse Casp8 siGenome SMART pool (Thermo
Scientiﬁc), Cat M-043044-01. siRNA oligos were transfected using HiPerFect
(Qiagen) 48 h before experimental conditions. Drosophila S2 cells were transfected
with Effectene (Qiagen) according to the manufacturer’s instructions. For
immunoﬂuorescence staining of mammalian cells, 105 cells were plated on 13mm
glass cover slips (VWR) and retro-transfected with 50 nmol siRNA as indicated.
Cells were then treated with the indicated biologics and ﬁxed in 4%
paraformaldehyde for 10min. Following 10min permeabilization with PBS
containing 0.5% Triton X-100, cells were incubated for 1 h in 5% BSA in PBS.
Respective primary antibodies were then added as follows: a-RIPK1 (BD
Bioscience), rabbit or goat a-CASP8 (Santa Cruz Biotechnology) and a-MYO7A
(Sigma). Alexa Fluor 633-conjugated phalloidin (Invitrogen) was used to stain actin
ﬁlaments. Secondary ﬂuorescent conjugated antibodies were then added as follows:
1:1,000 CF488A-donkey a-mouse and 1:1,000 CF633-donkey a-rabbit or 1:1,000
CF633-donkey a-rabbit. Cells were visualized by confocal microscopy (objective
 40, Zeiss LSM710). For Fig. 4c,d, SM was used at 100 nM and SKOV3 cells were
treated for 14–16 h. For Fig. 4f–i, TNF (Enzo Life Sciences) was used at 10 ngml 1
(unless stated otherwise) in conjunction with 10 nM SM and cells were treated for
8 h. Expression of CrmA was induced using 100 nM Tamoxifen, at least 4 h before
analysis.
Cell lysis and immunoprecipitation. Cells were lysed in 50mM Tris pH 7.5,
150mM NaCl, 0.1% Triton X-100, 10% glycerol and 1mM EDTA. Where lysates
were used for immunoprecipitations, complete protease inhibitor cocktail (Roche)
was added. Immunoprecipitations were performed using a-Myc or a-HA-agarose
beads (Sigma). Samples were examined by immunoblot analysis using either
chemiluminescence (Amersham Biosciences) or Odyssey Infrared Technology
(LI-COR Biosciences).
Proximity ligation assay. PLA was performed according to the manufacturer’s
protocol using the Duolink Detection Kit (Cambridge BioScience Ltd). Immuno-
ﬂuorescence staining of RIPK1 and CASP8 for the Duolink was carried out
following the above-described protocol for immunoﬂuorescence detection
up until the primary antibody incubation step. Probe incubation, ligation and
ampliﬁcation reaction were carried out according to the manufacturer instructions.
Cy3 signal ampliﬁcation was used for the assay. Cells were examined with a
confocal microscope (objective  40, Zeiss LSM 710).
FACS and DEVDase assays. For FACS and DEVDase assays, 104 cells were plated
in a 96-well plate and reverse siRNA transfection was performed with 50 nM total
siRNA for 40 h (25 nM of each individual siRNA balanced with control siRNA).
Cells were treated with TNF (500 pgml 1 or 10 ngml 1) plus SM in 150 ml for
24 h (FACS) or 5–6 h (DEVDase). For FACS analysis, medium containing dead
cells was transferred to a round-bottom 96-well plate, live cells were trypsinized in
50 ml, harvested with 100 ml of medium containing 1 mgml 1 propidum iodide
(Sigma) and combined with dead cells (total volume 300ml). The 96-well plate was
analysed by FACS using a plate reader. Data shown are from 5,000 cells per
condition. For DEVDase assays, the medium was removed after treatment and
20 ml 1% Triton lysis buffer was added to each well. Plates were placed at  80 C
to aid cell lysis. Plates were thawed at room temperature for 15min, after which
180 ml DEVDase assay mix (20 mM Ac-DEVD-AMC (Sigma), 1mM dithiothreitol,
50mM Tris pH 7.5, 150mM NaCl, 0.1% Triton X-100 and 5% glycerol) was added
to each well (it is noteworthy that cell lysates were not cleared). Reactions were
incubated at room temperature for up to 24 h. DEVDase activity was read at
380 nM excitation/460 nM emission.
Statistical analysis. For most experiments, data were analysed pairwise with
two-tailed t-tests assuming equal variance, using the following website: http://
studentsttest.com. Macrochaete data were analysed with Fisher’s exact test, using
the following website: http://www.quantitativeskills.com/sisa/statistics/ﬁveby2.htm.
References
1. McIlwain, D. R., Berger, T. & Mak, T. W. Caspase functions in cell death and
disease. Cold Spring Harb. Perspect. Biol. 7 (2015).
2. Meier, P. & Vousden, K. H. Lucifer’s labyrinth--ten years of path ﬁnding in cell
death. Mol. Cell 28, 746–754 (2007).
3. Miura, M. Apoptotic and non-apoptotic caspase functions in neural
development. Neurochem. Res. 36, 1253–1260 (2011).
4. Fuchs, Y. & Steller, H. Programmed cell death in animal development and
disease. Cell 147, 742–758 (2011).
5. Kuranaga, E. & Miura, M. Nonapoptotic functions of caspases: caspases as
regulatory molecules for immunity and cell-fate determination. Trends Cell
Biol. 17, 135–144 (2007).
6. Pop, C. & Salvesen, G. S. Human caspases: activation, speciﬁcity, and
regulation. J. Biol. Chem. 284, 21777–21781 (2009).
7. Mathur, P. & Yang, J. Usher syndrome: hearing loss, retinal degeneration and
associated abnormalities. Biochim. Biophys. Acta 1852, 406–420 (2015).
8. Williams, D. S. Usher syndrome: animal models, retinal function of Usher
proteins, and prospects for gene therapy. Vision Res. 48, 433–441 (2008).
9. Kiehart, D. P. et al. Drosophila crinkled, mutations of which disrupt
morphogenesis and cause lethality, encodes ﬂy myosin VIIA. Genetics 168,
1337–1352 (2004).
10. Quinn, L. M. et al. An essential role for the caspase dronc in developmentally
programmed cell death in Drosophila. J. Biol. Chem. 275, 40416–40424 (2000).
11. Meier, P., Silke, J., Leevers, S. J. & Evan, G. I. The Drosophila caspase DRONC is
regulated by DIAP1. EMBO J. 19, 598–611 (2000).
12. Hawkins, C. J., Yoo, S. J., Peterson, E. P., Wang, S. L., Vernooy, S. Y. &
Hay, B. A. The Drosophila caspase DRONC cleaves following glutamate or
aspartate and is regulated by DIAP1, HID, and GRIM. J. Biol. Chem. 275,
27084–27093 (2000).
13. Goyal, L., McCall, K., Agapite, J., Hartwieg, E. & Steller, H. Induction of
apoptosis by Drosophila reaper, hid and grim through inhibition of IAP
function. EMBO J. 19, 589–597 (2000).
14. Wang, S. L., Hawkins, C. J., Yoo, S. J., Muller, H. A. & Hay, B. A. The
Drosophila caspase inhibitor DIAP1 is essential for cell survival and is
negatively regulated by HID. Cell 98, 453–463 (1999).
15. Wing, J. P., Zhou, L., Schwartz, L. M. & Nambu, J. R. Distinct cell killing
properties of the Drosophila reaper, head involution defective, and grim genes.
Cell Death Differ. 5, 930–939 (1998).
16. Bergmann, A., Agapite, J., McCall, K. & Steller, H. The Drosophila gene
hid is a direct molecular target of Ras-dependent survival signaling. Cell 95,
331–341 (1998).
17. Grether, M. E., Abrams, J. M., Agapite, J., White, K. & Steller, H. The head
involution defective gene of Drosophila melanogaster functions in programmed
cell death. Genes Dev. 9, 1694–1708 (1995).
18. Xu, D., Li, Y., Arcaro, M., Lackey, M. & Bergmann, A. The CARD-carrying
caspase Dronc is essential for most, but not all, developmental cell death in
Drosophila. Development 132, 2125–2134 (2005).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10972 ARTICLE
NATURE COMMUNICATIONS | 7:10972 | DOI: 10.1038/ncomms10972 | www.nature.com/naturecommunications 11
19. Baum, J. S., Arama, E., Steller, H. & McCall, K. The Drosophila caspases Strica
and Dronc function redundantly in programmed cell death during oogenesis.
Cell Death Differ. 14, 1508–1517 (2007).
20. Kuranaga, E. et al. Drosophila IKK-related kinase regulates nonapoptotic
function of caspases via degradation of IAPs. Cell 126, 583–596 (2006).
21. Oshima, K. et al. IKK epsilon regulates F actin assembly and interacts
with Drosophila IAP1 in cellular morphogenesis. Curr. Biol. 16, 1531–1537
(2006).
22. Cullen, K. & McCall, K. Role of programmed cell death in patterning the
Drosophila antennal arista. Dev. Biol. 275, 82–92 (2004).
23. Wolff, T. & Ready, D. F. The beginning of pattern formation in the Drosophila
compound eye: the morphogenetic furrow and the second mitotic wave.
Development 113, 841–850 (1991).
24. Mendes, C. S. et al. Cytochrome c-d regulates developmental apoptosis in the
Drosophila retina. EMBO Rep. 7, 933–939 (2006).
25. Bergmann, A., Agapite, J. & Steller, H. Mechanisms and control of programmed
cell death in invertebrates. Oncogene 17, 3215–3223 (1998).
26. Abrams, J. M., White, K., Fessler, L. I. & Steller, H. Programmed cell death
during Drosophila embryogenesis. Development 117, 29–43 (1993).
27. Kanuka, H. et al. Drosophila caspase transduces Shaggy/GSK-3beta kinase
activity in neural precursor development. EMBO J. 24, 3793–3806 (2005).
28. Todi, S. V., Franke, J. D., Kiehart, D. P. & Eberl, D. F. Myosin VIIA defects,
which underlie the Usher 1B syndrome in humans, lead to deafness in
Drosophila. Curr. Biol. 15, 862–868 (2005).
29. Geisbrecht, E. R. & Montell, D. J. A role for Drosophila IAP1-mediated caspase
inhibition in Rac-dependent cell migration. Cell 118, 111–125 (2004).
30. Ragab, A., Buechling, T., Gesellchen, V., Spirohn, K., Boettcher, A. L. &
Boutros, M. Drosophila Ras/MAPK signalling regulates innate immune
responses in immune and intestinal stem cells. EMBO J. 30, 1123–1136 (2011).
31. Blanco-Sanchez, B., Clement, A., Fierro, Jr J., Washbourne, P. & Westerﬁeld, M.
Complexes of Usher proteins preassemble at the endoplasmic reticulum and are
required for trafﬁcking and ER homeostasis. Dis. Model Mech. 7, 547–559
(2014).
32. Soderberg, O. et al. Direct observation of individual endogenous protein
complexes in situ by proximity ligation. Nat. Methods 3, 995–1000 (2006).
33. Tenev, T. et al. The Ripoptosome, a signaling platform that assembles in
response to genotoxic stress and loss of IAPs. Mol. Cell 43, 432–448 (2011).
34. Feoktistova, M. et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8
containing intracellular cell death complex differentially regulated by cFLIP
isoforms. Mol. Cell 43, 449–463 (2011).
35. Wang, L., Du, F. & Wang, X. TNF-alpha induces two distinct caspase-8
activation pathways. Cell 133, 693–703 (2008).
36. Chan, F. K. et al. A role for tumor necrosis factor receptor-2 and receptor-
interacting protein in programmed necrosis and antiviral responses. J. Biol.
Chem. 278, 51613–51621 (2003).
37. Lin, Y., Devin, A., Rodriguez, Y. & Liu, Z. G. Cleavage of the death domain
kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13,
2514–2526 (1999).
38. Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits
RIPK3-dependent necrosis. Nature 471, 363–367 (2011).
39. Green, D. R., Oberst, A., Dillon, C. P., Weinlich, R. & Salvesen, G. S.
RIPK-dependent necrosis and its regulation by caspases: a mystery in ﬁve acts.
Mol. Cell 44, 9–16 (2011).
40. Silke, J. & Meier, P. Inhibitor of apoptosis (IAP) proteins-modulators of cell
death and inﬂammation. Cold Spring Harb. Perspect. Biol. 5 (2013).
41. Walczak, H. TNF and ubiquitin at the crossroads of gene activation, cell death,
inﬂammation, and cancer. Immunol. Rev. 244, 9–28 (2011).
42. Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via
two sequential signaling complexes. Cell 114, 181–190 (2003).
43. Balkwill, F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 9,
361–371 (2009).
44. Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inﬂammation.
Nature 517, 311–320 (2015).
45. Al-Gayyar, M. M. & Elsherbiny, N. M. Contribution of TNF-alpha to the
development of retinal neurodegenerative disorders. Eur. Cytokine Netw. 24,
27–36 (2013).
46. Williams, D. S. & Lopes, V. S. The many different cellular functions of MYO7A
in the retina. Biochem. Soc. Trans. 39, 1207–1210 (2011).
47. Dickens, L. S. et al. A death effector domain chain DISC model reveals a crucial
role for caspase-8 chain assembly in mediating apoptotic cell death. Mol. Cell
47, 291–305 (2012).
Acknowledgements
We are indebted to Ryu Ueda, Masayuki Miura and Daniel Kiehart for reagents and ﬂy
strains, and Shaomeng Wang for the gift of SMAC mimetic compounds. We thank
members of the Cell Death and Inﬂammation Team for support and critical reading of
the manuscript. We are very grateful to Frederik Wallberg, Brian Stramer, John Davis,
Eunice Chan, Alice Genevet, Nic Tapon and Yossi Kaplan for technical assistance and
helpful discussions. P.M. is supported by Breakthrough/Breast Cancer NOW, AICR,
MRC and Komen promise grants. A.B. is supported by a grant from the National
Institute of General Medical Science (NIGMS). D.W. is supported by the National
Institutes of Health (grant number EY07042). N.M. is funded by Breast Cancer Now
(2013MayPR023). We acknowledge NHS funding to the NIHR Biomedical Research
Centre.
Author contributions
M.H.O. designed and performed experiments shown in Figs 2a,b, 3b–e, 5c–e,h and
Supplementary Figs 1e,h and 2a–e. S.W.-J. designed and performed experiments shown
in Figs 1b–f, 4a,b, 6a,b and Supplementary Fig. 3a,b. G.L. designed and conducted the
experiments shown in Figs 6c,d, 7a–c and Supplementary Fig. 4a–f. N.M. and P.S.R.
conducted and analysed the experiments shown in Fig. 5f,g. R.F. designed and conducted
the experiments shown in Fig. 8a–c. L.A. and E.A. conducted and analysed the
experiments shown in Supplementary Fig. 3e. O.M. and C.M.D. designed, conducted and
analysed the experiments shown in Supplementary Figs 3c,d and 1i, respectively. M.T.
and A.B. designed, conducted and analysed the data shown in Fig. 2a and Supplementary
Fig. 1a–d. A.W. and M.G. conducted the mass spectrometry experiment and analysed the
data. D.W. provided the complementary DNA of MYO7A. D.R. conducted the scanning
electron microscopy picture shown in Supplementary Fig. 1i. M.H.O., S.W.-J., G.L., R.F.,
E.A., O.M., C.M.D., A.B., M.G., D.W., P.S.R., T.T., R.W., K.B. and P.M. analysed data,
provided helpful suggestions and discussions. M.H.O. and P.M. designed the study and
wrote the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Orme, M. H. et al. The unconventional myosin CRINKLED
and its mammalian orthologue MYO7A regulate caspases in their signalling roles.
Nat. Commun. 7:10972 doi: 10.1038/ncomms10972 (2016).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10972
12 NATURE COMMUNICATIONS | 7:10972 | DOI: 10.1038/ncomms10972 | www.nature.com/naturecommunications
